InMed Pharmaceuticals Inc.·4

Dec 26, 1:09 PM ET

WOUDENBERG MICHAEL 4

4 · InMed Pharmaceuticals Inc. · Filed Dec 26, 2023

Insider Transaction Report

Form 4
Period: 2023-12-23
WOUDENBERG MICHAEL
VP, Chem/Manufacturing/Control
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-12-23+65,00075,494 total
    Exercise: $0.37Exp: 2028-12-22Common shares (65,000 underlying)
Footnotes (1)
  • [F1]The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month).

Documents

1 file
  • 4
    ownership.xmlPrimary